KMT2A and acute myeloid leukemia: MLL-r ALL showed TERRA/28S levels 2.8-fold higher than in non-MLL-r ALL (p < 0.001) and 1.9-fold higher than in MLL-r AML (p < 0.005) (Figure 4C).